The Company anticipates completing enrollment of the 48-patient trial by the end of 2Q 2025 and releasing top-line data on the Phase 2a trial in 4Q 2025. Results from this trial are anticipated to be ...

Funded proposals will advance science to restore sight and prevent blindness through donation, transplantation, and research.

Scheicho Scheifa is haunted by the fear of going blind. A disease called trachoma has turned his eyelids inwards, causing his eyelashes to scar his corneas so badly that one has already turned opaque.

Optic neuritis: optic nerve swelling can cause painful eye movement and temporary vision loss. Toxic scleritis: a ...

This means rural residents with eye problems often face a long drive to get the care they need. For example, “our results ...

SightMD, New York's leading multi-specialty ophthalmology platform is proud to announce the acquisition of Sambursky Eye & Esthetics, a highly respected eye care practice that has served the community ...

On average, a baby's spontaneous eye blinking (SB) rate is fewer than four blinks per minute, which increases with age. The ...

Sure, you might be the ultimate staring contest winner if you stop blinking but there'd be consequences to face ...

A seemingly harmless nap turned into a life-changing ordeal for a Florida man who lost vision in one eye after sleeping with ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

They report a case of endophthalmitis and undertook a literature review to identify previous infections with this pathogen.

DATROWAY ® (datopotamab deruxtecan-dlnk) has been approved in the U.S. for the treatment of adult patients with unresectable or metastatic hormone receptor (HR) positive, HER2 negative (IHC 0, IHC 1+ ...